Nicholas Pappas, MD
Hand Surgery · Metairie, LANPI 1376603969
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $6,000 of the $8,579 with a category attached, or 69.9%. Biopro, Inc. accounts for 93.3% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2024 at $6,223 and has fallen 66.9% since, to $2,058 in 2025.
Across 33 payments — averaging $259.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biopro, Inc.$8K
- Johnson & Johnson$88
- Kowa Pharmaceuticals America, Inc.$86
- Convatec Inc.$78
- Axogen$54
- Endo USA, Inc.$38
- plus $234 from 11 others
What the payments were for
- Consulting fees$6,00070%
- Speaking & faculty fees$2,00023%
- Food & beverage$5797%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biopro, Inc. | 3 | $8,000 |
| Johnson & Johnson | 6 | $88 |
| Kowa Pharmaceuticals America, Inc. | 5 | $86 |
| Convatec Inc. | 3 | $78 |
| Axogen | 1 | $54 |
| Endo USA, Inc. | 2 | $38 |
| Amgen(2 entities) | 2 | $29 |
| Averitas Pharma Inc. | 1 | $28 |
| Paratek Pharmaceuticals, Inc. | 2 | $26 |
| IBSA Pharma Inc. | 1 | $25 |
| Zimmer Biomet | 1 | $24 |
| Sonex Health, Inc. | 1 | $20 |
| Amarin Pharma, Inc. | 1 | $19 |
| Bioventus LLC | 1 | $18 |
| Organogenesis Inc. | 1 | $16 |
| Vertex | 1 | $15 |
| AstraZeneca | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MOD THUMB$6,000
- PALINGEN$2,000
How this compares
$8,579 in reported general payments places this provider in the 85th percentile of 29 hand surgery providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 19 | $199 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 20 | $158 |
Paid to pharmacies, not to this prescriber.
Other hand surgery in Metairie
- Brandon DonnellyMetairie$8K
- Carol MeyerMetairie$878
- Leslie SiscoNew Orleans$169K
- Mark DodsonAlexandria$28K
- Ryan BlissBaton Rouge$11K
- Diego MirandaBossier City$10K
- Cameron BestMonroe$8K
- Sagar ShahLafayette$7K
- Brent McCartyCovington$7K
- Ross DunbarNew Orleans$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.